Influx Healthtech Limited (NSE:INFLUX)

Market Cap	5.79B
Revenue (ttm)	1.47B +40.0%
Net Income	205.39M +53.7%
EPS	9.35 +27.0%
Shares Out	23.15M
PE Ratio	26.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,600
Open	250.00
Previous Close	250.15
Day's Range	245.95 - 255.00
52-Week Range	120.00 - 298.75
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 20, 2026

About Influx Healthtech

Influx Healthtech Limited operates as a contract development and manufacturing organization that provides a range of healthcare products in India. The company offers ayurvedic and herbal formulations in form of tablets, capsules, powders, liquid orals, ointments, creams, lotions, and other applications; veterinary feed supplements in form of tablets, liquid orals, oral sprays, powders, bolus, gels, ointments, and creams for animals; and home care products, including bathroom cleaners, floor cleansers, phenyle liquids, and other household cleani...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2003
• Employees: 163
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INFLUX

Financial Performance

In fiscal year 2026, Influx Healthtech's revenue was 1.47 billion, an increase of 40.04% compared to the previous year's 1.05 billion. Earnings were 205.39 million, an increase of 53.66%.